Weekly Investment Analysts’ Ratings Updates for McKesson (MCK)

Several brokerages have updated their recommendations and price targets on shares of McKesson (NYSE: MCK) in the last few weeks:

• 8/19/2026 – McKesson had its price target raised by Barclays PLC from $925.00 to $1,000.00. They now have an “overweight” rating on the stock.
• 8/19/2026 – McKesson is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $845.00 price target on the stock.
• 8/19/2026 – McKesson is now covered by Royal Bank Of Canada. They set a “sector perform” rating and a $845.00 price target on the stock.
• 8/11/2026 – McKesson had its price target raised by Wells Fargo & Company from $812.00 to $933.00. They now have an “equal weight” rating on the stock.
• 8/7/2026 – McKesson had its “overweight” rating reaffirmed by Morgan Stanley.
• 8/6/2026 – McKesson was given a new $1,015.00 price target by Robert W. Baird.
• 8/6/2026 – McKesson had its “outperform” rating reaffirmed by Evercore Inc.
• 8/6/2026 – McKesson had its price target raised by TD Cowen from $989.00 to $1,006.00. They now have a “buy” rating on the stock.
• 8/6/2026 – McKesson had its price target raised by UBS Group AG from $1,050.00 to $1,080.00. They now have a “buy” rating on the stock.
• 7/24/2026 – McKesson had its price target raised by Citigroup Inc. from $945.00 to $1,000.00. They now have a “buy” rating on the stock.
• 7/21/2026 – McKesson had its price target lowered by TD Cowen from $1,012.00 to $989.00. They now have a “buy” rating on the stock.
• 7/7/2026 – McKesson was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be issued a $0.94 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio (DPR) is 8.78%.

Insider Transactions at McKesson

In other news, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total value of $6,715,898.28. Following the sale, the chief executive officer directly owned 5,919 shares in the company, valued at approximately $4,697,081.64. This trade represents a 58.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 22,289 shares of company stock valued at $17,406,854. Corporate insiders own 0.06% of the company’s stock.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.